These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33358277)

  • 1. The Immunologists' Guide to Pandemic Preparedness.
    Marín-Hernández D; Hupert N; Nixon DF
    Trends Immunol; 2021 Feb; 42(2):91-93. PubMed ID: 33358277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines: acting on the evidence.
    Nat Med; 2021 Feb; 27(2):183. PubMed ID: 33542537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and deployment of COVID-19 vaccines for those most vulnerable.
    Koff WC; Schenkelberg T; Williams T; Baric RS; McDermott A; Cameron CM; Cameron MJ; Friemann MB; Neumann G; Kawaoka Y; Kelvin AA; Ross TM; Schultz-Cherry S; Mastro TD; Priddy FH; Moore KA; Ostrowsky JT; Osterholm MT; Goudsmit J
    Sci Transl Med; 2021 Feb; 13(579):. PubMed ID: 33536277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Shot Wonder: A Vaccine Against All Coronaviruses.
    Mertz L
    IEEE Pulse; 2020; 11(6):2-5. PubMed ID: 33315546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology Lessons from the SARS-CoV-2 Pandemic.
    Yokoyama WM; Hogquist KA; O'Shea JJ
    Annu Rev Immunol; 2021 Apr; 39():v-vii. PubMed ID: 33939926
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunity to glycan α-Gal and possibilities for the control of COVID-19.
    la Fuente J; Gortázar C; Cabezas-Cruz A
    Immunotherapy; 2021 Feb; 13(3):185-188. PubMed ID: 33307805
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI).
    Knight V; Askar MZ; Ntrivalas E; Nandiwada SL; Peterson LK; Tebo AE; Kadkhoda K; Schmitz JL; Naides SJ; Snyder MR; Sadighi Akha AA
    J Immunol Methods; 2021 May; 492():112994. PubMed ID: 33626382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced protection in aging adults and pandemic response.
    Schenkelberg T
    Biochem Biophys Res Commun; 2021 Jan; 538():218-220. PubMed ID: 33213845
    [No Abstract]   [Full Text] [Related]  

  • 10. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanzania's position on the COVID-19 pandemic.
    Mfinanga SG; Mnyambwa NP; Minja DT; Ntinginya NE; Ngadaya E; Makani J; Makubi AN
    Lancet; 2021 Apr; 397(10284):1542-1543. PubMed ID: 33864748
    [No Abstract]   [Full Text] [Related]  

  • 13. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could mixing COVID vaccines boost immune response?
    Ledford H
    Nature; 2021 Feb; 590(7846):375-376. PubMed ID: 33547431
    [No Abstract]   [Full Text] [Related]  

  • 15. T cell-oriented strategies for controlling the COVID-19 pandemic.
    Noh JY; Jeong HW; Kim JH; Shin EC
    Nat Rev Immunol; 2021 Nov; 21(11):687-688. PubMed ID: 34497383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological surrogate endpoints of COVID-2019 vaccines: the evidence we have versus the evidence we need.
    Jin P; Li J; Pan H; Wu Y; Zhu F
    Signal Transduct Target Ther; 2021 Feb; 6(1):48. PubMed ID: 33531462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From mRNA sensing to vaccines.
    Fauci AS; Merad M; Swaminathan S; Hur S; Topol E; Fitzgerald K; Reis e Sousa C; Corbett KS; Bauer S
    Immunity; 2021 Dec; 54(12):2676-2680. PubMed ID: 34739870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.